Literature DB >> 17172468

The adenoviral E4orf6 protein induces atypical apoptosis in response to DNA damage.

Lori S Hart1, David Ornelles, Constantinos Koumenis.   

Abstract

Adenoviral proteins interact with host-cell proteins to either exploit or inhibit cellular functions for the purpose of viral propagation. E4orf6, the 34-kDa gene product of the E4 gene, interacts with the double-strand break repair (DSBR) protein DNA-dependent protein kinase and cooperates with binding partner E1B-55K to degrade MRE11, preventing viral DNA concatemer formation. We previously demonstrated that E4orf6 radiosensitizes human tumor cells through the inhibition of DSBR, notably in the absence of E1B-55K. Here, we report that E4orf6 prolongs the signaling of DNA damage by inhibiting the activity of protein phosphatase 2A (PP2A), the phosphatase responsible for dephosphorylating gammaH2AX. The inhibition of PP2A occurs without significant disruption of the DNA re-ligation rate. Prolonged signaling of DNA damage in the presence of E4orf6 initiates caspase-dependent and independent cell death. This is accompanied by poly(ADP-ribose) polymerase (PARP) hyperactivation and the translocation of apoptosis-inducing factor (AIF) from the mitochondria to the nucleus. Knockdown of AIF by shRNA rescues the radiosensitization induced by E4orf6. Taken together, these data suggest that E4orf6 disrupts cellular DSBR signaling by inhibiting PP2A, leading to prolonged H2AX phosphorylation, hyperactivation of PARP, and AIF translocation to the nucleus. The function of E4orf6 as an inhibitor of PP2A and activator of PARP in the absence of other adenoviral gene products is of importance in delineating the adenovirus-host cell interplay.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17172468     DOI: 10.1074/jbc.M610405200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Evaluation of continuous low dose rate versus acute single high dose rate radiation combined with oncolytic viral therapy for prostate cancer.

Authors:  Chunyan Liu; Yonggang Zhang; Minzhi Maggie Liu; Haoming Zhou; Wasim Chowdhury; Shawn E Lupold; Ted L Deweese; Ronald Rodriguez
Journal:  Int J Radiat Biol       Date:  2010-03       Impact factor: 2.694

2.  Sequential activation of poly(ADP-ribose) polymerase 1, calpains, and Bax is essential in apoptosis-inducing factor-mediated programmed necrosis.

Authors:  Rana S Moubarak; Victor J Yuste; Cédric Artus; Aïda Bouharrour; Peter A Greer; Josiane Menissier-de Murcia; Santos A Susin
Journal:  Mol Cell Biol       Date:  2007-04-30       Impact factor: 4.272

Review 3.  Chromatin at the intersection of viral infection and DNA damage.

Authors:  Caroline E Lilley; Mira S Chaurushiya; Matthew D Weitzman
Journal:  Biochim Biophys Acta       Date:  2009-07-17

4.  Interleukin-5 priming of human eosinophils alters siglec-8 mediated apoptosis pathways.

Authors:  Esra Nutku-Bilir; Sherry A Hudson; Bruce S Bochner
Journal:  Am J Respir Cell Mol Biol       Date:  2007-08-09       Impact factor: 6.914

5.  E1B and E4 oncoproteins of adenovirus antagonize the effect of apoptosis inducing factor.

Authors:  Roberta L Turner; John C Wilkinson; David A Ornelles
Journal:  Virology       Date:  2014-04-15       Impact factor: 3.616

6.  Adeno-associated virus replication induces a DNA damage response coordinated by DNA-dependent protein kinase.

Authors:  Rachel A Schwartz; Christian T Carson; Christine Schuberth; Matthew D Weitzman
Journal:  J Virol       Date:  2009-04-01       Impact factor: 5.103

7.  OSU-03012 stimulates PKR-like endoplasmic reticulum-dependent increases in 70-kDa heat shock protein expression, attenuating its lethal actions in transformed cells.

Authors:  Margaret A Park; Adly Yacoub; Mohammed Rahmani; Guo Zhang; Lori Hart; Michael P Hagan; Stuart K Calderwood; Michael Y Sherman; Costas Koumenis; Sarah Spiegel; Ching-Shih Chen; Martin Graf; David T Curiel; Paul B Fisher; Steven Grant; Paul Dent
Journal:  Mol Pharmacol       Date:  2008-01-08       Impact factor: 4.436

Review 8.  Oncolytic viruses in head and neck cancer: a new ray of hope in the management protocol.

Authors:  Ps Shilpa; R Kaul; S Bhat; N Sultana; P Pandeshwar
Journal:  Ann Med Health Sci Res       Date:  2014-09

9.  The Adenovirus E4orf4 Protein Provides a Novel Mechanism for Inhibition of the DNA Damage Response.

Authors:  Anna Brestovitsky; Keren Nebenzahl-Sharon; Peter Kechker; Rakefet Sharf; Tamar Kleinberger
Journal:  PLoS Pathog       Date:  2016-02-11       Impact factor: 6.823

Review 10.  Viral control of mitochondrial apoptosis.

Authors:  Lorenzo Galluzzi; Catherine Brenner; Eugenia Morselli; Zahia Touat; Guido Kroemer
Journal:  PLoS Pathog       Date:  2008-05-30       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.